Head-to-head · WeighScore
PreventiveMD vs Sprout Health
The verdict
Sprout Health takes it — 79.8/100 to 76.4/100.
Sprout Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A LegitScript-certified desk that pairs low-cost compounded semaglutide and tirzepatide with a real brand-name Wegovy and Zepbound path — and a near-frictionless, often visit-free start.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | PreventiveMD | Sprout Health |
|---|---|---|
| WeighScore | 76.4/100 | 79.8/100 |
| Grade | C | C+ |
| Site position | #53 | #26 |
| Semaglutide | $83/mo (as low as, term not published, all-in, compounded) | $299/mo |
| Tirzepatide | $97/mo (as low as, term not published, all-in, compounded) | $349/mo |
| Coverage | 36 states | Not disclosed |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Injection only | Injection only |
Site position #53 · C
Strengths
- Compounded semaglutide from $83/mo and tirzepatide from $97/mo, billed as one all-in monthly price
- Brand Wegovy, Zepbound, and Foundayo (oral GLP-1) available on the same platform
- US-licensed provider reviews requests within 24 hours — no video visit required
- You aren't charged until a provider approves; checkout places an authorization hold only
- LegitScript-certified; works exclusively with state-licensed US 503A compounding pharmacies
Where it loses points
- Both figures are 'as low as' rates and the qualifying term is not published anywhere — the checkout is gated, so whether $97 is month-to-month or a multi-month prepay cannot be established before signing up
- Brand-name routes are priced separately and do carry a fee: $49/mo membership plus medication from $149/mo for Foundayo and Wegovy, from $299/mo for Zepbound
- No state count is published, and a state-variant waitlist implies some states are unserved
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Site position #26 · C+
FDAWarning letter issued to Sprout Health Partners LLC dba Sprout Health in September 2025. See the FDA warning-letter database.
Strengths
- LegitScript-certified with a listed address and contact line
- Both compounded ($149 semaglutide / $199 tirzepatide) and a genuine brand-name Wegovy/Zepbound route
- Low-friction intake — no labs and often no telehealth visit required
Where it loses points
- Compounded semaglutide and tirzepatide are not FDA-approved
- No oral or sublingual route — injectable only
- Thin transparency — no named medical director, and state availability is quiz-gated
- "No labs, no visit" convenience also means lighter clinical oversight
Featured provider
Sprout Health
Sprout Health scores 79.8/100 (C+). A LegitScript-certified desk that pairs low-cost compounded semaglutide and tirzepatide with a real brand-name Wegovy and Zepbound path — and a near-frictionless, often visit-free start.
Commercial relationships affect this placement. The score comparison above is separate.
FDAWarning letter issued to Sprout Health Partners LLC dba Sprout Health in September 2025. See the FDA warning-letter database.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.